This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsMonte Rosa Therapeutics
Monte Rosa Therapeutics company logo
Develops molecular glue degrader medicines for cancer, autoimmune, and inflammatory diseases51-200 Employees

Monte Rosa Therapeutics careers

Develops molecular glue degrader medicines for cancer, autoimmune, and inflammatory diseases
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.

Director – Quality GCP

In office • Boston
4 weeks ago

Manager Clinical Data

In office • Boston
2 months ago

Manager – Quality GCP

In office • Boston
Valuation

$0

Funded over

1 round

Latest round

Seed (Jan 2026)